Polikistik over sendromunda over volümü ölçümü ve metabolik değerlendirme: kesitsel gözlemsel çalişma Metabolic evaluation and measurement of ovarian volume in polycystic ovary sydrome: a cross-sectional observational study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

  2014cited by this paper
• Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.

  2013cited by this paper
• Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome

  2013cited by this paper
• The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis

  2013cited by this paper
• Cardiometabolic aspects of the polycystic ovary syndrome.

  2012cited by this paper
• Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.

  2011cited by this paper
• Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

  2010cited by this paper
• The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

  2009cited by this paper
• Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.

  2008cited by this paper
• Metabolic and cardiovascular consequences of polycystic ovary syndrome.

  2008cited by this paper
• Cardiometabolic features of polycystic ovary syndrome

  2008cited by this paper
• Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

  2007cited by this paper
• Polycystic ovarian syndrome.

  2006cited by this paper
• Metabolic syndrome: time for action.

  2004cited by this paper
• Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.

  2003cited by this paper
• Developmental origin of polycystic ovary syndrome - a hypothesis.

  2002cited by this paper
• Polycystic ovary syndrome: the new millenium

  2001cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• No citing papers are available for this paper.